Ligand Pharmaceuticals, Inc. (LGND)

196.56 +3.59 (+1.86%) USD  |  NASDAQ  |  Jan 20, 16:00
200.00 +3.44 (+1.75%) Pre-Market: 08:49
More

Ligand Pharmaceuticals Total Long Term Assets (Quarterly)

Total Long Term Assets (Quarterly) Chart

View Total Long Term Assets (Quarterly) for LGND.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Assets (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Long Term Assets (Quarterly) Range, Past 5 Years

View Total Long Term Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Assets (Quarterly) Benchmarks

View Total Long Term Assets (Quarterly) Benchmarks
Start Trial
Merck & Co., Inc. Upgrade
Johnson & Johnson Upgrade
Elanco Animal Health, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
Krystal Biotech, Inc. Upgrade